CD20 antibodies with increased FC receptor binding affinity and effector function

Details for Australian Patent Application No. 2004287643 (hide)

Owner Roche GlycArt AG

Inventors Puntener, Ursula; Umana, Pablo; Ferrara, Claudia; Mossner, Ekkehard; Suter, Tobias; Brunker, Peter

Agent Davies Collison Cave

Pub. Number AU-B-2004287643

PCT Pub. Number WO2005/044859

Priority 60/517,096 05.11.03 US

Filing date 5 November 2004

Wipo publication date 19 May 2005

Acceptance publication date 17 November 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/044859 Priority application(s): WO2005/044859

10 November 2011 Alteration of Name

  The name of the applicant has been altered to Roche GlycArt AG 2005

17 November 2011 Application Accepted

  Published as AU-B-2004287643

9 February 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 12 Dec 2011. Address for service in Australia - Davies Collison Cave Level 14 255 Elizabeth Street Sydney NSW 2000 2005

31 May 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Dec 2011 2005

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004287645-Variants of human glycoprotein hormone alpha chain: compositions and uses thereof

2004287642-Allosteric modulators of metabotropic glutamate receptors